{"nct_id":"NCT03713619","title":"This Was a Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS).","status":"COMPLETED","status_verified_date":"2024-10","start_date":"2019-01-31","start_date_type":"ACTUAL","primary_completion_date":"2021-10-01","primary_completion_date_type":"ACTUAL","completion_date":"2022-07-26","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}